You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 117 No. 12, December 1982 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Transluminal Dilation

An Alternative?

K. Wayne Johnston, MD, FRCS(C); Ronald F. Colapinto, MD, FRCP; Ronald J. Baird, MD, FRCS(C)

Arch Surg. 1982;117(12):1604-1610.


Abstract

• In a prospective study, 384 peripheral arterial transluminal dilations were evaluated, using clinical and vascular laboratory criteria, and analyzed by the life-table method. The overall cumulative success rate was 58.9±3.3% (mean±SEM) after two years but was higher if the iliac segment was dilated, only one site was dilated, the clinical indication was claudication, the distal vessels were normal, the ankle-brachial BP ratio was more than 0.35, or if the patient was younger than 55 years. The complication rate was 3.9%. If the dilation failed, the symptoms were worse in 8% and the ankle-brachial BP ratio fell in 23%. After successful dilation in patients with normal distal vessels, residual claudication persisted in 34%, and the ankle-brachial BP ratio remained abnormal in 40%. Although the overall success rate of transluminal dilation was lower than for a comparable surgical procedure, dilation does have a role in the management of localized peripheral vascular disease.

(Arch Surg 1982;117:1604-1610)



Author Affiliations

From the Departments of Surgery (Drs Johnston and Baird) and Radiology (Dr Colapinto), Toronto General Hospital and the University of Toronto.


Footnotes

Accepted for publication July 12, 1982.

Read before the 30th scientific meeting of the International Cardiovascular Society, Boston, June 19, 1982.

Reprint requests to 9 Eaton N, Room 215, 101 College St, Toronto, Ontario, Canada M5G 1L7.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Early Hemodynamic Effects of Percutaneous Transluminal Angioplasty in Superficial Femoral Artery Disease
Labropoulos et al.
VASC ENDOVASCULAR SURG 1997;31:615-621.
ABSTRACT  

Determinants of Failure in Superficial Femoral Artery Angioplasty
El-Bayar et al.
VASC ENDOVASCULAR SURG 1994;28:539-547.
ABSTRACT  

Determinants of Failure in Superficial Femoral Artery Angioplasty
El-Bayar et al.
ANGIOLOGY 1992;43:877-885.
ABSTRACT  

The Role of Percutaneous Transluminal Angioplasty and Femoropopliteal Bypass in Patients with Threatened Limb
Fletcher et al.
VASC ENDOVASCULAR SURG 1988;22:226-230.
ABSTRACT  

Crossover Femorofemoropopliteal Sequential Bypass for Combined Ipsilateral Iliac and Femoropopliteal Occlusive Disease
Schuler et al.
Arch Surg 1984;119:456-461.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1982 American Medical Association. All Rights Reserved.